Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...
Following the CDC’s major revisions to the US childhood immunization schedule, Noel T. Brewer, PhD, distinguished professor ...
Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum ...
Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum treatment drop-off. Drawing on global data, Toska examined HIV incidence ...
The rise in CRC in adults younger than 65 underscores the need for early screening and prevention efforts. The report’s ...
As the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up, leading HIV experts reflected on the ...
Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.
AJMC: Your findings suggest that roughly 1 in 10 Medicare Advantage enrollees may face forced disenrollment in 2026. From a ...
Medicaid expansion correlates with lower breast cancer mortality, yet non-Hispanic Black women and lowest-income ...
Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
In 524,817 adults with T2D, GLP-1 RA use was associated with lower incident alcohol, cocaine, cannabis, opioid, and nicotine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results